CFD
SANA icon

Creative Financial Designs’s Sana Biotechnology SANA Stock Holding History

Creative Financial Designs’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$349 Hold
100
– – ﹤0.01% 2166
2026
Q1 		$288 Hold
100
– – ﹤0.01% 2063
2025
Q4 		$407 Buy
+100
New +$448 ﹤0.01% 1929

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Creative Financial Designs's SANA Position: Q2 2026 in Review

Creative Financial Designs held its Sana Biotechnology (SANA) position steady in Q2 2026 at 100 shares worth $349. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

Creative Financial Designs first reported a position in SANA in Q4 2025 and has held it in 3 quarters since. The position peaked at $407 in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Creative Financial Designs held 100 shares of Sana Biotechnology worth $349 as of Q2 2026.
  • Creative Financial Designs left its Sana Biotechnology share count unchanged in Q2 2026.
  • Sana Biotechnology made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2166 holding.
  • Creative Financial Designs first reported a position in Sana Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • Creative Financial Designs's Sana Biotechnology position peaked at $407 in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.